Home  >  Products  >  LPL (lipoprotein lipase) Blocking Peptide (the C terminal of LPL)(100ug)
LPL (lipoprotein lipase) Blocking Peptide (the C terminal of LPL)(100ug)

LPL (lipoprotein lipase) Blocking Peptide (the C terminal of LPL)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LPL Antibody (ARP60284_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60284
Size: 100ug
Weight: 50kDa
Gene: 4023
Format: Lyophilized powder
Target: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Alternative names: HDLCQ11; LIPD
See Full Product Listings >